Evidence against the hypothesis that BCL-2 inhibits apoptosis through an anti-oxidant effect |
| |
Authors: | Gardner A Xu F H Fady C Sarafian T Tu Y Lichtenstein A |
| |
Affiliation: | Department of Medicine, VA West Los Angeles Hospital-UCLA Medical Center, Los Angeles, California, USA. |
| |
Abstract: | We contrasted possible protection against apoptosis afforded by either BCL-2 expression or anti-oxidant inhibitors in the same tumor target challenged by two distinct triggers of apoptosis. Exposure of L929 fibroblasts to tumor necrosis factor (TNF) or etoposide (VP-16) induced apoptotic death with similar kinetics. Enforced expression of BCL-2 significantly protected against apoptosis induced by VP-16 but had no effect against TNF-induced apoptosis. In contrast, the anti-oxidants desferrioxamine, butylated hydroxyanisol and N-acetyl cysteine all inhibited TNF-induced apoptosis in a concentration-dependent fashion. Although exposure to VP-16 resulted in a significant generation of intracellular oxyradicals, the above three anti-oxidant inhibitors had no effect on VP-16-induced apoptotic death. Interestingly, enforced expression of BCL-2 also inhibited the ability of VP-16 to generate oxy-radicals and to depress intracellular glutathione levels. These results indicate that BCL-2 can exert anti-oxidant effects but argue against the hypothesis that these effects are critical to its protection against apoptosis. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|